{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:41:55Z","timestamp":1781739715176,"version":"3.54.5"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0140180","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T17:26:54Z","timestamp":1444238814000},"page":"e0140180","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers"],"prefix":"10.1371","volume":"10","author":[{"given":"Emily","family":"Vogtmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Corley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy M.","family":"Almers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris R.","family":"Cardwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam J.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian C.","family":"Abnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"key":"ref1","unstructured":"National Osteoporosis Foundation. NOF Releases New Data Detailing the Prevalence of Osteoporosis: National Osteoporosis Foundation; 2013 [cited 2013 8\/28]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nof.org\/news\/1009\" xlink:type=\"simple\">http:\/\/www.nof.org\/news\/1009<\/ext-link>."},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-149-6-200809160-00007","article-title":"Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians","volume":"149","author":"A Qaseem","year":"2008","journal-title":"Annals of internal medicine"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","article-title":"Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis","volume":"148","author":"C MacLean","year":"2008","journal-title":"Annals of internal medicine"},{"issue":"14","key":"ref4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","article-title":"Esophagitis associated with the use of alendronate","volume":"335","author":"PC de Groen","year":"1996","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMc0808738","article-title":"Reports of esophageal cancer with oral bisphosphonate use","volume":"360","author":"DK Wysowski","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"17","key":"ref6","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMc096026","article-title":"More on reports of esophageal cancer with oral bisphosphonate use","volume":"360","author":"B Abrahamsen","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jbmr.1481","article-title":"Esophageal and gastric cancer incidence and mortality in alendronate users","volume":"27","author":"B Abrahamsen","year":"2012","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2010.1098","article-title":"Exposure to oral bisphosphonates and risk of esophageal cancer","volume":"304","author":"CR Cardwell","year":"2010","journal-title":"JAMA"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1111\/j.1532-5415.2011.03693.x","article-title":"Alendronate and risk of esophageal cancer: a nationwide population-based study in Taiwan","volume":"59","author":"YM Chen","year":"2011","journal-title":"Journal of the American Geriatrics Society"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"c4444","DOI":"10.1136\/bmj.c4444","article-title":"Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort","volume":"341","author":"J Green","year":"2010","journal-title":"BMJ"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1055-9965.EPI-12-0259","article-title":"Oral bisphosphonates and risk of esophageal cancer: a dose-intensity analysis in a nationwide population","volume":"21","author":"YF Ho","year":"2012","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1007\/s10620-010-1198-1","article-title":"Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett&apos;s esophagus","volume":"55","author":"DM Nguyen","year":"2010","journal-title":"Digestive diseases and sciences"},{"issue":"17","key":"ref13","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMc096026","article-title":"More on reports of esophageal cancer with oral bisphosphonate use","volume":"360","author":"DH Solomon","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00223-011-9539-4","article-title":"Occurrence of gastrointestinal cancer in users of bisphosphonates and other antiresorptive drugs against osteoporosis","volume":"89","author":"P Vestergaard","year":"2011","journal-title":"Calcified tissue international"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"f114","DOI":"10.1136\/bmj.f114","article-title":"Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data","volume":"346","author":"Y Vinogradova","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"e47616","DOI":"10.1371\/journal.pone.0047616","article-title":"Bisphosphonates and risk of upper gastrointestinal cancer\u2013-a case control study using the General Practice Research Database (GPRD)","volume":"7","author":"E Wright","year":"2012","journal-title":"PloS one"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2105\/AJPH.82.5.703","article-title":"Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology","volume":"82","author":"N Krieger","year":"1992","journal-title":"American journal of public health"},{"key":"ref18","unstructured":"WHOCC. ATC\/DDD Index 2013 2013 [cited 2013 8\/28]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.whocc.no\/atc_ddd_index\/\" xlink:type=\"simple\">http:\/\/www.whocc.no\/atc_ddd_index\/<\/ext-link>."},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"ME Charlson","year":"1987","journal-title":"Journal of chronic diseases"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2036.1999.00488.x","article-title":"Alendronate gastric ulcers","volume":"13","author":"DY Graham","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ctrv.2011.09.003","article-title":"Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature","volume":"38","author":"M Gnant","year":"2012","journal-title":"Cancer treatment reviews"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.2010.217182","article-title":"Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field","volume":"60","author":"S Ogino","year":"2011","journal-title":"Gut"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10552-015-0596-2","article-title":"Proceedings of the second international molecular pathological epidemiology (MPE) meeting","volume":"26","author":"S Ogino","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/modpathol.2012.214","article-title":"Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease","volume":"26","author":"S Ogino","year":"2013","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"20","key":"ref25","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.3748\/wjg.v20.i20.6055","article-title":"Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention","volume":"20","author":"F Bishehsari","year":"2014","journal-title":"World journal of gastroenterology: WJG"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1055-9965.EPI-15-0094","article-title":"Association between Body Mass Index and Mortality for Colorectal Cancer Survivors: Overall and by Tumor Molecular Phenotype","volume":"24","author":"PT Campbell","year":"2015","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0140180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T04:57:53Z","timestamp":1567227473000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0140180"}},"subtitle":[],"editor":[{"given":"Chi-Ling","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0140180","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,7]]}}}